Please assess the completion status of the following clinical trial:

Trial Title: The Study of Minocycline for Negative and Cognitive Symptoms in Schizophrenia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* male and female,were aged 18-40 years~* were currently diagnosed with DSM-IV schizophrenia~* were able to comprehend the cognition test~* patients or guardian signed informed consent,were able to comprehend the procedure and aims of the study,agreed to join the study~* patient's current antipsychotic medication regimen must be stable~* must be in a stable living arrangement~Exclusion Criteria:~* had ever been hypersensitivity to minocycline or tetracycline;~* had acute,unstable,significant,or untreated medical illness besides schizophrenia~* were pregnant or breast-feeding;~* had a DSM-IV diagnosis of substance abuse or dependency;~* had a tendency to suicide or Violence,self-harm;~* had taken immunosuppressive agents in the preceding 3 months before study entry;~* had influenza or fever in the preceding 2 weeks before study entry;~* had a DSM-IV diagnosis of emotional psychosis,Mental retardation,etc.~* has suicidal attempts or ideation or violent behavior within the last 12 months~* patient has mental retardation or severe organic brain syndromes~* treatment with Electroconvulsive Therapy (ECT) within 6 months prior to screening

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- placebo (Type: PLACEBO_COMPARATOR): Subjects will be given with 200mg/day placebo(100mg,bid) and variable dose SGA. All drugs will be administered orally.
- minocycline (Type: ACTIVE_COMPARATOR): Subjects will be given with 200mg/day minocycline (100mg,bid)and variable dose SGA.All drugs will be administered orally.

Based on this trial design, predict the completion outcome and termination type (if applicable).